Sculptra® is an enduring treatment approved by the FDA for restoration and/or correction of the signs of facial fat loss, or lipoatrophy.

Facial fat loss, or lipoatrophy, is the loss of fat beneath the skin, which can result in sunken cheeks, indentations, and hollow eyes. Sculptra® is a safe, synthetic, and biocompatible material that is injected below the surface of the skin in the area of fat loss. It provides a gradual and significant increase in skin thickness, improving the appearance of folds and sunken areas. No skin testing is required.

Sculptra® has been safely used outside the United States since 1999 in over 150,000 patients under the trade names New-Fill^TM and Sculptra®.

What It Does
Sculptra® is an injectable product that restores and corrects the signs of facial fat loss by replacing lost volume. Sculptra® provides an increase in skin thickness, helping to create a more natural facial appearance in those with facial lipoatrophy.

Sculptra® is composed of poly-L-lactic acid, a synthetic material. Sculptra® is not made from human or animal sources and does not require a skin test. Poly-L-lactic acid (PLLA) is a biocompatible (does not harm the body), biodegradable (able to be broken down by the body) material that has been widely used for many years in surgical products. The effects are long-lasting; they were shown in a clinical study to last for up to 2 years after the first treatment session.